Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:43 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2305–2328 of 6,761 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CHANGE Study Clear all

Conditions: Celiac Disease
Interventions: Not listed
Lead sponsor: Celgene; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Dallas, Texas • Seattle, Washington

Conditions: Overactive Bladder
Interventions: 500 mg NDS-446; Drug
Lead sponsor: Loyola University; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Dementia, Mild, Mild Cognitive Impairment, Disability Physical, Impairment, Cognitive, Caregiver Burden, Quality of Life, Depression
Interventions: CAPABLE Family - Open Label Pilot, CAPABLE Family - Randomized Control Trial; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 60 Years and older
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Childhood Obesity
Interventions: Competency Based Approaches to Community Health (COACH); Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 6 Years to 12 Years
Enrollment: 750 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obesity
Interventions: STAR - Study of Technology to Accelerate Research; Behavioral
Lead sponsor: Harvard Pilgrim Health Care; Other
Eligibility: 6 Years to 12 Years
Enrollment: 549 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity
Interventions: TOPS; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Sedentary Behavior
Interventions: Behavioral Change Techniques; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 45 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity
Interventions: Exercise intervention, Delayed exercise intervention; Other
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Synovial Sarcoma, Myxoid Liposarcoma
Interventions: afamitresgene autoleucel (previously ADP-A2M4); Genetic
Lead sponsor: USWM CT, LLC; Industry
Eligibility: 10 Years to 75 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2038
U.S. locations: 17
States / cities: Duarte, California • Palo Alto, California • Aurora, Colorado + 13 more

Conditions: Cancer, Malignancies Multiple
Interventions: AYA-PARTNER Navigation Intervention; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 39 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Anxiety
Interventions: Brief group neuroeducation; Behavioral
Lead sponsor: Oregon State University; Other
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 2
States / cities: Denver, Colorado

Conditions: Subacute Stroke, Acute Stroke
Interventions: MindPod Dolphin VGT, Bimanual Arm Trainer VGT; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years to 90 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pediatric Solid Tumor, Neuroblastoma
Interventions: B7-H3.CD28Z.CART, Fludarabine, Cyclophosphamide; Biological · Drug
Lead sponsor: Robbie Majzner; Other
Eligibility: 9 Months to 30 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiovascular Diseases, Coronary Artery Disease, Heart Diseases, Myocardial Ischemia, Kidney Disease, End Stage Renal Failure on Dialysis
Interventions: Cardiac Catheterization, Coronary Artery Bypass Graft Surgery, Percutaneous Coronary Intervention, Lifestyle, Medication; Procedure · Behavioral · Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years and older
Enrollment: 777 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Prostate Cancer
Interventions: 89Zr-DFO-huJ591; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Abdominal Aortic Aneurysms
Interventions: Fenestrated Endovascular Graft or Company Manufactured Terumo Aortic Fenestrated TREO Endovascular Graft; Device
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2055
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Atypical Squamous Cell of Undetermined Significance, Cervical Carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3, Health Status Unknown, Human Papillomavirus Infection, Low Grade Cervical Squamous Intraepithelial Neoplasia, Stage 0 Cervical Cancer
Interventions: Cervical Papanicolaou Test, Cytology Specimen Collection Procedure, Questionnaire Administration, Screening Method; Other · Procedure
Lead sponsor: University of Washington; Other
Eligibility: 21 Years and older · Female only
Enrollment: 1,335 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Seattle, Washington

Conditions: Ovarian Cancer
Interventions: Ad5.SSTR/TK.RGD, Ganciclovir (GCV); Genetic · Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older · Female only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Brain Activity Related to Opioid Administration, Brain Activity Related to Drug Liking
Interventions: Observational study in patients receiving fentanyl for surgery; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Interventions: Venetoclax, Umbralisib, Ublituximab, Lenalidomide; Drug · Biological
Lead sponsor: TG Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 3
States / cities: Chicago, Illinois • Rochester, New York • Cleveland, Ohio

Conditions: Stage IV Pancreatic Cancer
Interventions: Gemcitabine, PEGPH20, Placebo; Drug
Lead sponsor: Halozyme Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 8
States / cities: Fayetteville, Arkansas • San Francisco, California • Indianapolis, Indiana + 5 more

Conditions: Essential Tremor
Interventions: Not listed
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 85 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Hyperinsulinemia, Insulin Resistance, Obesity
Interventions: metformin and rosiglitazone; Drug
Lead sponsor: New York Medical College; Other
Eligibility: 35 Years to 55 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Diabetes
Interventions: Insulin, glucose and staple isotopes; Procedure
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Chula Vista, California

Search by objective public record fields.

A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease

Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks

CAPABLE Family Pilot - Adapting CAPABLE for Older Adults With Mild Cognitive Impairment (MCI)/Early Stage Dementia and Their Care Partners

The ADAPT Trial: Adapting Evidence-Based Obesity Interventions in Community Settings

Study of Technology to Accelerate Research

Study to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net Clinic

Behavior Change Techniques (BCTs) to Improve Low Intensity Physical Activity in Older Adults

Exercise as a Buffer Against Stress-induced Overeating

Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Feasibility Pilot of AYA-PARTNER

Randomized Controlled Trial of Spanish Brief Group Neuroscience-Informed Cognitive-Behavior Therapy for Anxiety

Feasibility of Video Gaming Technology for Arm Recovery Early Post-stroke

B7-H3.CD28Z.CART in Solid Tumors

ISCHEMIA-Chronic Kidney Disease Trial

Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer

Physician Modified Endovascular Grafts

Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening

A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers

Characterizing the EEG Signature of Fentanyl and Its Association With Drug Liking

Phase I/II Study of Venetoclax or Lenalidomide in Combination With Ublituximab and Umbralisib in Subjects With Relapsed or Refractory CLL/SLL and NHL

Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer

Deep Brain Stimulation Effects in Essential Tremor

EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance

Experimental Study to Validate the Modified Glucose Disposal Test